Acute coronary syndrome
Conditions
Interventions
Control group:Given the complexity of ACS clinical manifestations and the individualized treatment principles in clinical treatment guidelines, referring to the "Management Guidelines for Acute Corona
Experimental group:The conventional Western medicine treatment in the experimental group was the same as that in the control group. In addition, electroacupuncture treatment was added. (1) Acupoints:
Shenting, Baihui a
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
36 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Met the diagnostic criteria of ACS and were successfully transferred to the CCU after undergoing PCI in our hospital. (2) Age ranged from 36 to 80 years old (including the critical point), with no gender restrictions. (3) Killip cardiac function classification was I-III grade. (4) Met the diagnostic criteria for anxiety state, with mild to moderate anxiety state, that is, the GAD-7 score was between 5 and 14 points (including the critical point). (5) Had no history of anxiety state before, that is, the primary caregiver filled out the informed version of the Hospital Anxiety and Depression Scale (Hospital Anxiety and Depression Scale, HADS), and the anxiety subscale (HADS-A) score was = 7 points. (6) Volunteered to participate in this study and signed the informed consent form. Those who met all six of the above criteria can be included in this clinical trial.
Exclusion criteria
Exclusion criteria: (1) Those who experienced severe complications after PCI, such as acute coronary artery occlusion, no-reflow of the coronary artery, coronary artery rupture or perforation, perioperative myocardial infarction, etc. (2) Those with severe functional impairment of major organs or acute infectious diseases, such as respiratory failure, cerebral hemorrhage, cerebral infarction, liver failure, kidney failure, etc. (3) Those with severe intellectual disability and unable to cooperate with scale assessment. (4) Those with damaged or infected skin at the acupuncture site and not suitable for acupuncture, or those who cannot tolerate conventional antiplatelet, lipid-lowering, etc. drugs. (5) Pregnant women, lactating women, or those planning to conceive in the near future. (6) Those participating in another clinical study simultaneously. Any of the above conditions will disqualify a participant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate of clinical efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| The scoring of TCM syndromes;Myocardial injury indicators;Inflammatory response indicators;Central nervous system injury indicators;Heart rate variability;Left Ventricle Ejection Fraction;Major Adverse Cardiovascular Events; | — |
Countries
China
Contacts
Public ContactLi Jing
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed